7MFE image
Entry Detail
PDB ID:
7MFE
EMDB ID:
Title:
Autoinhibited BRAF:(14-3-3)2 complex with the BRAF RBD resolved
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-04-09
Release Date:
2022-01-26
Method Details:
Experimental Method:
Resolution:
4.07 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Serine/threonine-protein kinase B-raf
Chain IDs:A
Chain Length:766
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:14-3-3 protein zeta/delta
Chain IDs:B (auth: C), C (auth: B)
Chain Length:245
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP A SER modified residue
Ligand Molecules
Primary Citation
Structural insights into the BRAF monomer-to-dimer transition mediated by RAS binding.
Nat Commun 13 486 486 (2022)
PMID: 35078985 DOI: 10.1038/s41467-022-28084-3

Abstact

RAF kinases are essential effectors of RAS, but how RAS binding initiates the conformational changes needed for autoinhibited RAF monomers to form active dimers has remained unclear. Here, we present cryo-electron microscopy structures of full-length BRAF complexes derived from mammalian cells: autoinhibited, monomeric BRAF:14-3-32:MEK and BRAF:14-3-32 complexes, and an inhibitor-bound, dimeric BRAF2:14-3-32 complex, at 3.7, 4.1, and 3.9 Å resolution, respectively. In both autoinhibited, monomeric structures, the RAS binding domain (RBD) of BRAF is resolved, revealing that the RBD forms an extensive contact interface with the 14-3-3 protomer bound to the BRAF C-terminal site and that key basic residues required for RBD-RAS binding are exposed. Moreover, through structure-guided mutational studies, our findings indicate that RAS-RAF binding is a dynamic process and that RBD residues at the center of the RBD:14-3-3 interface have a dual function, first contributing to RAF autoinhibition and then to the full spectrum of RAS-RBD interactions.

Legend

Protein

Chemical

Disease

Primary Citation of related structures